DYN ▲ +0.4% - Dyne Therapeutics, Inc. $DYN - Dyne Therapeutics to Present Preclinical Data for Multiple Development Candidates for Duchenne Muscular Dystrophy (DMD) at 27th Annual NMSG Scientific Meeting Dyne Therapeutics rose 0.4% following news that the company will present preclinical data for multiple DMD development candidates at the 27th Annual NMSG Scientific Meeting. The presentation of early-stage research data on muscular dystrophy programs appears to have provided modest positive sentiment for the biotech company's pipeline progress. 03-SEP-2026 07:30 AM ET